MyFinsight
Home
Blog
About
Contact
Download
Download image
Net income (loss)
$44,717K
Accounts payable
$1,140K
Stock-based compensation
expense
$421K
Reduction in the operating
right of use assets
$32K
Net cash used in
operating activities
$1,908K
Canceled cashflow
$44,402K
Net decrease in
cash, cash...
$778K
Canceled cashflow
$1,130K
Deferred revenue
-$41,250K
Accrued expenses
-$1,438K
Prepaid expenses and
other assets
$805K
Operating lease
liabilities
-$589K
Loss on sale of assets
held for sale
$320K
Payment of principal
related to finance lease...
-$60K
Net cash (used in)
provided by financing...
-$1,130K
Canceled cashflow
$60K
Payment of finance
liability from failed...
$1,190K
Back
Back
Cash Flow
source: myfinsight.com
Carisma Therapeutics Inc. (CARM)
Carisma Therapeutics Inc. (CARM)